These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 7909277

  • 1. Relationship of p53 overexpression and up-regulation of proliferating cell nuclear antigen with the clinical course of non-small cell lung cancer.
    Ebina M, Steinberg SM, Mulshine JL, Linnoila RI.
    Cancer Res; 1994 May 01; 54(9):2496-503. PubMed ID: 7909277
    [Abstract] [Full Text] [Related]

  • 2. Evaluations of p53 immunoreactivity, nucleolar organizer regions, and proliferating cell nuclear antigen in non-small cell lung carcinoma.
    Oyama T, Osaki T, Nose N, Ichiki Y, Inoue M, Imoto H, Yoshimatsu T, Kodate M, Uramoto H, Mizoue T, Yano K, Yasumoto K.
    Anticancer Res; 2000 May 01; 20(1B):505-10. PubMed ID: 10769714
    [Abstract] [Full Text] [Related]

  • 3. Prognostic significance of the tumor suppressor gene maspin in non-small cell lung cancer.
    Hirai K, Koizumi K, Haraguchi S, Hirata T, Mikami I, Fukushima M, Yamagishi S, Kawashima T, Okada D, Shimizu K, Kawamoto M.
    Ann Thorac Surg; 2005 Jan 01; 79(1):248-53. PubMed ID: 15620951
    [Abstract] [Full Text] [Related]

  • 4. Y-box-binding protein-1 expression is not correlated with p53 expression but with proliferating cell nuclear antigen expression in non-small cell lung cancer.
    Yoshimatsu T, Uramoto H, Oyama T, Yashima Y, Gu C, Morita M, Sugio K, Kohno K, Yasumoto K.
    Anticancer Res; 2005 Jan 01; 25(5):3437-43. PubMed ID: 16101161
    [Abstract] [Full Text] [Related]

  • 5. Expression of nuclear factor-kappaB and its clinical significance in nonsmall-cell lung cancer.
    Zhang Z, Ma J, Li N, Sun N, Wang C.
    Ann Thorac Surg; 2006 Jul 01; 82(1):243-8. PubMed ID: 16798222
    [Abstract] [Full Text] [Related]

  • 6. Enhanced apoptosis predicts shortened survival in non-small cell lung carcinoma.
    Törmänen U, Eerola AK, Rainio P, Vähäkangas K, Soini Y, Sormunen R, Bloigu R, Lehto VP, Pääkkö P.
    Cancer Res; 1995 Dec 01; 55(23):5595-602. PubMed ID: 7585640
    [Abstract] [Full Text] [Related]

  • 7. The utility of p53 immunostaining of transbronchial biopsy specimens of lung cancer: p53 overexpression predicts poor prognosis and chemoresistance in advanced non-small cell lung cancer.
    Kawasaki M, Nakanishi Y, Kuwano K, Yatsunami J, Takayama K, Hara N.
    Clin Cancer Res; 1997 Jul 01; 3(7):1195-200. PubMed ID: 9815799
    [Abstract] [Full Text] [Related]

  • 8. Prognostic significance of p53 protein expression and DNA ploidy in surgically treated non-small cell lung carcinomas.
    Mørkve O, Halvorsen OJ, Skjaerven R, Stangeland L, Gulsvik A, Laerum OD.
    Anticancer Res; 1993 Jul 01; 13(3):571-8. PubMed ID: 8391242
    [Abstract] [Full Text] [Related]

  • 9. p53 expression in non small cell lung cancer: clinical and biological correlations.
    Fontanini G, Bigini D, Vignati S, Macchiarini P, Pepe S, Angeletti CA, Pingitore R, Squartini F.
    Anticancer Res; 1993 Jul 01; 13(3):737-42. PubMed ID: 8100413
    [Abstract] [Full Text] [Related]

  • 10. [Relationship between expressions of p53, c-erbB2 genes, proliferating cell nuclear antigen and prognosis of patients with ovarian epithelial carcinoma].
    Li JD, Li MD, Li YF, Huang X, Liu JH, Liu FY, Zhang CQ.
    Ai Zheng; 2002 Mar 01; 21(3):292-6. PubMed ID: 12451998
    [Abstract] [Full Text] [Related]

  • 11. Proliferating cell nuclear antigen expression and argyrophilic nucleolar organizer regions as factors influencing prognosis of surgically treated lung cancer patients.
    Ishida T, Kaneko S, Akazawa K, Tateishi M, Sugio K, Sugimachi K.
    Cancer Res; 1993 Oct 15; 53(20):5000-3. PubMed ID: 8104690
    [Abstract] [Full Text] [Related]

  • 12. Prognostic values of stromal proportion and PCNA, Ki-67, and p53 proteins in patients with resected adenocarcinoma of the lung.
    Demarchi LM, Reis MM, Palomino SA, Farhat C, Takagaki TY, Beyruti R, Saldiva PH, Capelozzi VL.
    Mod Pathol; 2000 May 15; 13(5):511-20. PubMed ID: 10824922
    [Abstract] [Full Text] [Related]

  • 13. Neural networks as a prognostic tool for patients with non-small cell carcinoma of the lung.
    Bellotti M, Elsner B, Paez De Lima A, Esteva H, Marchevsky AM.
    Mod Pathol; 1997 Dec 15; 10(12):1221-7. PubMed ID: 9436967
    [Abstract] [Full Text] [Related]

  • 14. bcl-2 and p53 protein expression in non-small cell lung cancers: correlation with survival time.
    Ohsaki Y, Toyoshima E, Fujiuchi S, Matsui H, Hirata S, Miyokawa N, Kubo Y, Kikuchi K.
    Clin Cancer Res; 1996 May 15; 2(5):915-20. PubMed ID: 9816250
    [Abstract] [Full Text] [Related]

  • 15. Correlation between survivin expression and prognosis in non-small cell lung cancer.
    Atikcan S, Unsal E, Demirag F, Köksal D, Yilmaz A.
    Respir Med; 2006 Dec 15; 100(12):2220-6. PubMed ID: 16650973
    [Abstract] [Full Text] [Related]

  • 16. Altered retinoblastoma protein expression in nonsmall cell lung cancer: its synergistic effects with altered ras and p53 protein status on prognosis.
    Dosaka-Akita H, Hu SX, Fujino M, Harada M, Kinoshita I, Xu HJ, Kuzumaki N, Kawakami Y, Benedict WF.
    Cancer; 1997 Apr 01; 79(7):1329-37. PubMed ID: 9083154
    [Abstract] [Full Text] [Related]

  • 17. Relevance of proliferative and pro-apoptotic factors in non-small-cell lung cancer for patient survival.
    Volm M, Koomägi R.
    Br J Cancer; 2000 May 01; 82(10):1747-54. PubMed ID: 10817513
    [Abstract] [Full Text] [Related]

  • 18. Cluster analysis of p-glycoprotein, c-erb-B2 and P53 in relation to tumor histology strongly indicates prognosis in patients with operable non-small cell lung cancer.
    Bozcuk H, Gumus A, Ozbilim G, Sarper A, Kucukosmanoglu I, Ozbudak IH, Artac M, Ozdogan M, Samur M, Kaya A, Savas B.
    Med Sci Monit; 2005 Jun 01; 11(6):HY11-20. PubMed ID: 15917726
    [Abstract] [Full Text] [Related]

  • 19. Proliferating cell nuclear antigen, p53, and c-erbB-2 expression in relation to clinicopathological variables and prognosis in cancer of the ampulla of Vater.
    Ajiki T, Kamigaki T, Hasegawa Y, Fujino Y, Suzuki Y, Takeyama Y, Ku Y, Kuroda Y.
    Hepatogastroenterology; 2001 Jun 01; 48(41):1266-70. PubMed ID: 11677943
    [Abstract] [Full Text] [Related]

  • 20. Cyclin D1 overexpression is an indicator of poor prognosis in resectable non-small cell lung cancer.
    Keum JS, Kong G, Yang SC, Shin DH, Park SS, Lee JH, Lee JD.
    Br J Cancer; 1999 Sep 01; 81(1):127-32. PubMed ID: 10487623
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.